Multiomics – News and Features

A new study reveals that IL-12, an inflammatory molecule, accelerates Alzheimer’s disease by damaging brain cells and preventing plaque clearance. Blocking IL-12 in mice halted disease-related changes, suggesting a potential new therapy.

Studying how proteins cluster and organize themselves at the cell membrane could pave the way for innovative cystic fibrosis treatments.

Thomas Moehring highlights how advanced technologies such as mass spectrometry, automation and AI are accelerating biomarker discovery and clinical applications, leading to breakthroughs in diagnostics and therapies for complex diseases.

Many labs are adopting Internet of Things (IoT)-integrated laboratory information management systems (LIMS). This article explores the benefits, key applications, challenges and future directions of IoT-enabled LIMS.

New research uses genomics to provide insights into how organisms adjust their metabolism, taking a step toward understanding the complex functions of the metabolic network.

A machine learning algorithm that analyzes immune "fingerprints" could be used to detect complex, hard-to-diagnose diseases.

A new study from researchers at the University of Leipzig Medical Center and collaborators, has discovered a rare but serious side effect of CAR T-cell therapy in a 63-year-old patient.

Researchers from New York University have uncovered that cancer cells also work together to source nutrients from their environment — a cooperative process that was previously overlooked but may be a promising target for treating cancer.

Researchers have successfully disrupted the hepatitis B virus's ability to infect human liver cells in the laboratory using a compound already in clinical trials against cancer, laying the groundwork for potential drug development.

A new immunotherapy target called a cryptic antigen may be key in helping the immune system fight ovarian cancer.